No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Benzoates / adverse effects
-
Benzoates / therapeutic use*
-
Blood Coagulation / drug effects
-
Clinical Trials, Phase II as Topic / statistics & numerical data
-
Clinical Trials, Phase III as Topic / statistics & numerical data
-
Fibrin Fibrinogen Degradation Products / analysis
-
Fibrinolysis / drug effects
-
Hemorrhage / chemically induced
-
Humans
-
Hydrazines / adverse effects
-
Hydrazines / therapeutic use*
-
Platelet Count
-
Pulmonary Embolism / etiology
-
Pulmonary Embolism / prevention & control*
-
Purpura, Thrombocytopenic, Idiopathic / complications*
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use*
-
Receptors, Fc / therapeutic use*
-
Receptors, Thrombopoietin / agonists*
-
Recombinant Fusion Proteins / adverse effects
-
Recombinant Fusion Proteins / therapeutic use*
-
Retrospective Studies
-
Thrombophilia / blood
-
Thrombophilia / drug therapy*
-
Thrombophilia / etiology
-
Thrombopoietin / adverse effects
-
Thrombopoietin / therapeutic use*
-
Venous Thrombosis / etiology
-
Venous Thrombosis / prevention & control*
Substances
-
Benzoates
-
Fibrin Fibrinogen Degradation Products
-
Hydrazines
-
Pyrazoles
-
Receptors, Fc
-
Receptors, Thrombopoietin
-
Recombinant Fusion Proteins
-
fibrin fragment D
-
MPL protein, human
-
Thrombopoietin
-
romiplostim
-
eltrombopag